Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients
Advances in DNA sequencing have made genetic testing fast and affordable, but limitations of testing processes are impeding realisation of patient benefits. Ovarian cancer exemplifies the potential value of genetic testing and the shortcomings of current pathways to access testing. Approximately 15%...
Главные авторы: | George, A, Riddell, D, Seal, S, Talukdar, S, Mahamdallie, S, Ruark, E, Cloke, V, Slade, I, Kemp, Z, Gore, M, Strydom, A, Banerjee, S, Hanson, H, Rahman, N |
---|---|
Формат: | Journal article |
Язык: | English |
Опубликовано: |
Nature Research
2016
|
Схожие документы
-
The ICR639 CPG NGS validation series: A resource to assess analytical sensitivity of cancer predisposition gene testing [version 1; referees: 2 approved]
по: Shazia Mahamdallie, и др.
Опубликовано: (2018-06-01) -
Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN.
по: Fowler, A, и др.
Опубликовано: (2016) -
CoverView: a sequence quality evaluation tool for next generation sequencing data [version 1; referees: 2 approved]
по: Márton Münz, и др.
Опубликовано: (2018-04-01) -
The Quality Sequencing Minimum (QSM): providing comprehensive, consistent, transparent next generation sequencing data quality assurance [version 1; referees: 2 approved, 1 approved with reservations]
по: Shazia Mahamdallie, и др.
Опубликовано: (2018-04-01) -
Accurate clinical detection of exon copy number variants in a targeted NGS panel using DECoN [version 1; referees: 2 approved]
по: Anna Fowler, и др.
Опубликовано: (2016-11-01)